Synovial sarcoma: frequency of nonaggressive MR characteristics

M F Blacksin1, J R Siegel, J Benevenia

  • 1Department of Radiology, University of Medicine and Dentistry of New Jersey, Newark 07103, USA.

Abstract

Insights

Synovial sarcoma can present with nonaggressive MRI features, particularly smaller lesions (<5 cm) that appear well-circumscribed and homogeneous. Larger tumors often show heterogeneous characteristics, aiding in diagnosis.

Area of Science:

  • Oncology
  • Radiology
  • Medical Imaging

Background:

  • Synovial sarcoma is a rare soft tissue malignancy.
  • Accurate pre-operative diagnosis is crucial for appropriate management.
  • Magnetic Resonance (MR) imaging plays a key role in soft tissue tumor evaluation.

Purpose of the Study:

  • To characterize the MR appearance of synovial sarcoma.
  • To determine the prevalence of a nonaggressive imaging presentation in synovial sarcoma.

Main Methods:

  • Retrospective analysis of MR examinations from 15 patients with confirmed synovial sarcoma.
  • Evaluation of imaging features including size, margins, homogeneity, internal architecture, signal intensity (T1 and T2 weighted), and bone invasion.

Main Results:

  • 33% of lesions (5/15) were small (<5 cm), well-circumscribed, and homogeneous, with specific T1 and T2 signal intensities.
  • Larger lesions (10/15, mean length 11.3 cm) exhibited increased heterogeneity and variable margins.

Conclusions:

  • Synovial sarcoma can present with two distinct MR imaging patterns.
  • Small, homogeneous lesions may mimic benign masses, potentially leading to suboptimal surgical approaches.
  • Larger lesions are typically more heterogeneous, aiding in differentiation.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...